Atticus Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3
Closed 619
2022
Q3
$0 Hold
3
﹤0.01% 612
2022
Q2
$0 Hold
3
﹤0.01% 637
2022
Q1
$1K Hold
3
﹤0.01% 574
2021
Q4
$1K Sell
3
-328
-99% -$88.4K ﹤0.01% 430
2021
Q3
$96K Buy
+331
New +$84.9K 0.04% 175

Other funds holding RGEN

Atticus Wealth Management's RGEN Position: Q4 2022 in Review

Atticus Wealth Management sold out of Repligen (RGEN) in Q4 2022, closing a stake of 3 shares.

Atticus Wealth Management first reported a position in RGEN in Q3 2021 and held it in 5 quarters. The position peaked at $96K in Q3 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • Atticus Wealth Management reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
  • Atticus Wealth Management sold 3 Repligen shares in Q4 2022.
  • Atticus Wealth Management first reported a position in Repligen in Q3 2021 and held it in 5 quarters.
  • Atticus Wealth Management's Repligen position peaked at $96K in Q3 2021.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on Atticus Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.